10x Genomics Inc (LTS:0A88)
$ 14.72 0.6324 (4.47%) Market Cap: 1.78 Bil Enterprise Value: 1.46 Bil PE Ratio: 0 PB Ratio: 2.46 GF Score: 60/100

10X Genomics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 03:45PM GMT
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

On day 3 of our Healthcare conference, I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. Delighted to have 10x Genomics join us this morning. And representing the company are; Serge Saxonov, CEO; and Justin McAnear, CFO. So welcome, gentlemen.

Before we can get started, I have a quick disclaimer I need to run through. Please note, the webcast is for Morgan Stanley's clients an appropriate employees only. The webcast is not for members of the press. And if you are with the press, please disconnect and reach out separately. For important disclosures, please see morganstanley.com/researchdisclosures.

And if you have any questions, please reach out to your sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that Serge, just to set the stage, could you provide an overview of how for single cell and, more recently, spatial biology are adding depth to research.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot